A Comparative Clinical Study To Evaluate The Efficacy Of Vasa Arka Nebulization And Kantakari Arka Nebulization In the Management Of Kaphaj Kasa In Children
试验速览
- 阶段
- 2/3 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 40
- 试验地点
- 1
- 主要终点
- 1.Reduce Symptoms Of Kasa vega
研究概览
简要总结
Physiologically Kapha dosha is predominant in balya-awastha , may cause various kaphaj vyadhi such as kaphaj kasa. This is one of the most common disease that affect Pranvaha shrotas and further health of the child. Acute respiratory tract infection associated with the upper respiratory pathologies,. Intake of Arka and its benifits in tackling the signs and symptoms of cough, As these situation the inhalation routes developed so far is the better method to reduce the undesirable effects of systemic administration. In Arka Prakash author has explained Vasa Arka in the form of Nebulization also have anti asthmatic effect in human.
Present study aimed to re-evaluate the effect of Vasa Arka Nebulization on Kaphaj kasa. In the study subject will be advised for Nasal Inhalation of Vasa Arka Nebulization and dose of administration will be calculated based on child age group. Vasa Arka Nebulization will be advised in form of Nebulization for 10 days and follow up done in every 10th days for 1 month.
Assessment will be done on the basis of subjective and objective criteria adopted for the study.
研究设计
- 研究类型
- Interventional
- 分配方式
- Other
- 盲法
- None
入排标准
- 年龄范围
- 3.00 Year(s) 至 12.00 Year(s)（—）
入选标准
- •1.Patients Of Either Gender From Age 3-12 years.
- •2.Patients Have Classical symptoms of Kaphaj Kasa.
- •3.Patients complaint of bodyache along with mild to moderate symptoms of cough, wheezing, shortness of breathing, sore throat etc.
- •4.Subject willing to participate in study after consent.
排除标准
- •Chronic disorder like Tuberculosis, Pneumonia, RDS, CHD, COPD(Chronic obstructive pulmonary disease), pleural effusion, will be excludate form study.
- •2.Children with any congenital deformity.
- •3.Patient on long term medication as any steroids medicine.
结局指标
主要结局
1.Reduce Symptoms Of Kasa vega
时间窗: At Baseline, 10 Days of Active intervention, during Treatment follow up after 10th day and 10th day after post follow up in one month
(Frequency of Cough)
时间窗: At Baseline, 10 Days of Active intervention, during Treatment follow up after 10th day and 10th day after post follow up in one month
2.Nisthavati Ghanam Kapham (Productive Cough) Reduce
时间窗: At Baseline, 10 Days of Active intervention, during Treatment follow up after 10th day and 10th day after post follow up in one month
次要结局
- 1.Reduce obstruction of upper respiratory tract.(10 Days of Active intervention, during Treatment follow up after 10 day and 10th day after post follow up in one month.)
研究者
Dr Dikshit Swarnkar
Shri Narayan Prasad Awasthi Govt. Ayurveda College Raipur (C.G.)